Central Serous Chorioretinopathy

Central Serous Chorioretinopathy is a retinal condition that affects largeley the working age group of the population.  It is self limiting in a majority but can leave behind lasting damage to the central vision.

Who gets it

Central Serous Chorioretinopathy is also known as Central Serous Retinopathy (CSR) in the UK.  It is a retinal condition where there is leakage of fluid under the central retina (which subserves the maximum clarity of vision).  It tends to affect people in their middle age and affects men much more commonly than women.  The precise reason as to what causes CSR is unknown.  It has been found more often in individuals who have Type A Behavioural Personality who are characterised by high-drive and competitiveness.  Most patients that I treat tell me that they have been under stress. There is also evidence that patients who take corticosteroid medication are at a higher risk of developing CSR.


Patients who have developed Central Serous Chorioretinopathy notice problems with their central vision or distortion and this disease often affects one eye predominantly.  It is self limiting disease in the majority but there is a risk of developing choroidal neovascularisation similar to wet are-related macular degeneration (AMD).

Treatment options

Central Serous Chorioretinopathy tends to settle down down on its own in a majority of patients.  There is a role for Aspirin treatment and Argon laser photocoagulation.  Certain subset of patients get better with Photodynamic Therapy.

External resources

Content coming soon…